Chief Financial Officer

Aphios Corporation is a clinical-stage biotechnology company advancing differentiated nanotechnology platforms and next-generation therapeutics across oncology, neurodegenerative disease, infectious disease, and substance-use disorder.

As the company enters its next phase of growth and capital-markets readiness, Aphios is seeking an experienced Part-Time / Fractional Chief Financial Officer (CFO) with direct biotech IPO and public-company preparation experience to work closely with the CEO and Board.

This role is designed for a senior biotech finance executive who has successfully guided companies through IPO preparation, public-company readiness, and alternative public-market pathways, and who is interested in a high-impact, flexible leadership engagement rather than a full-time operating role.

​

Key Responsibilities

• Lead financial strategy, capital planning, and cash-flow management for a growth-stage biotech
• Prepare the company for IPO and public-company readiness, including internal controls, reporting infrastructure, and governance
• Oversee GAAP-compliant financial reporting, audit readiness, and risk management
• Develop and maintain long-range financial models aligned with clinical, regulatory, and commercialization milestones
• Support investor relations, Board communications, and external stakeholder engagement
• Structure and evaluate PIPE financings, crossover fund participation, and late-stage private capital strategies
• Advise on NASDAQ and NYSE uplisting requirements and readiness timelines
• Evaluate SPAC or de-SPAC-adjacent opportunities, as appropriate, without over-engineering the business
• Interface with investment banks, auditors, securities counsel, and regulatory advisors
• Oversee grant accounting and compliance (e.g., NIH, SBIR/STTR)

​

Qualifications

• Bachelor’s degree in Finance, Accounting, or related field
• (MBA, CPA, or CFA strongly preferred)
• 10–15+ years of senior financial leadership experience in biotechnology or life sciences
• Demonstrated experience taking a biotech company through IPO or IPO readiness
• Strong working knowledge of SEC reporting, GAAP, internal controls, and audit processes
• Experience with venture-backed, clinical-stage, or R&D-intensive organizations
• Familiarity with PIPEs, crossover investors, and public-market capital strategy
• Executive presence with the ability to engage effectively at the Board and investor level
• Comfortable operating in lean, entrepreneurial environments

​

Why This Role

• High-impact executive position with direct influence on capital-markets strategy
• Flexible, part-time / fractional engagement suitable for seasoned CFOs
• Opportunity to help position a differentiated biotech platform for public-market execution
• Mission-driven company with strong ESG alignment and meaningful therapeutic ambition

​​

How to Apply

Note: This is a syndicated job post. Fractional Jobs found it on the web, but we are not working with the client directly, so we don't have control over or knowledge of the application process. To apply, click on the "View Application" button and follow the application's instructions. Let us know how it goes!